IRIS PubliCatt

Pagano, Livio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.173
NA - Nord America 7.823
AS - Asia 2.124
SA - Sud America 42
AF - Africa 34
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 8
Totale 18.222
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.745
DE - Germania 3.083
SE - Svezia 1.485
CN - Cina 1.366
UA - Ucraina 812
IT - Italia 792
IE - Irlanda 510
FR - Francia 412
SG - Singapore 344
GB - Regno Unito 251
RU - Federazione Russa 239
FI - Finlandia 223
PL - Polonia 166
IN - India 143
TR - Turchia 102
JP - Giappone 47
MX - Messico 38
BE - Belgio 35
CA - Canada 34
HK - Hong Kong 32
NL - Olanda 32
ES - Italia 30
BR - Brasile 19
CI - Costa d'Avorio 19
RO - Romania 19
CZ - Repubblica Ceca 18
AU - Australia 15
CH - Svizzera 15
IL - Israele 15
TH - Thailandia 13
VN - Vietnam 11
CL - Cile 10
IR - Iran 9
EU - Europa 7
GR - Grecia 7
HU - Ungheria 7
KR - Corea 7
SA - Arabia Saudita 6
AR - Argentina 4
AT - Austria 4
CR - Costa Rica 4
HR - Croazia 4
JO - Giordania 4
KZ - Kazakistan 4
LT - Lituania 4
MD - Moldavia 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CO - Colombia 3
ME - Montenegro 3
NG - Nigeria 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PE - Perù 3
TW - Taiwan 3
ZA - Sudafrica 3
DK - Danimarca 2
EC - Ecuador 2
EG - Egitto 2
ET - Etiopia 2
GH - Ghana 2
ID - Indonesia 2
MA - Marocco 2
MK - Macedonia 2
MY - Malesia 2
PH - Filippine 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BZ - Belize 1
EE - Estonia 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MT - Malta 1
NP - Nepal 1
PA - Panama 1
SC - Seychelles 1
VE - Venezuela 1
Totale 18.222
Salva come PNG Salva come JPEG
Città #
Chandler 1.635
Ashburn 579
Jacksonville 527
Dublin 503
San Mateo 403
Ann Arbor 312
Wilmington 282
Nanjing 277
Dearborn 219
Singapore 205
Nürnberg 186
Woodbridge 182
Boston 181
Houston 177
Moscow 177
Milan 173
New York 171
Lawrence 170
Beijing 161
Bremen 158
Hangzhou 154
Warsaw 148
Cattolica 125
Zhengzhou 117
Princeton 103
Chicago 99
Nanchang 90
Redwood City 88
Marseille 87
Rome 80
Seattle 79
Fairfield 78
Izmir 77
Boardman 69
Redmond 69
Munich 63
Mountain View 60
Shenyang 59
Hebei 58
Kunming 52
Los Angeles 47
Tianjin 46
Lancaster 45
Norwalk 45
Changsha 43
University Park 43
Shanghai 40
Jiaxing 38
Leawood 34
Brussels 33
Cambridge 32
Philadelphia 31
Washington 31
Hong Kong 30
Henderson 25
Guangzhou 24
Auburn Hills 23
Helsinki 23
Falls Church 22
Fremont 22
Hefei 20
Pune 20
Andover 19
Cuauhtémoc 19
Abidjan 18
Jinan 18
Busto Arsizio 17
Augusta 16
Tokyo 16
Florence 15
Phoenix 15
Edinburgh 14
Simi Valley 14
Mexico City 13
Lappeenranta 12
Toronto 12
Changchun 11
Costa Mesa 11
Indiana 11
Kraków 11
Monmouth Junction 11
Nuremberg 11
Brno 9
Hanoi 9
London 9
Madrid 9
Ningbo 9
São Paulo 9
Taizhou 9
Bern 8
Forest City 8
Kansas City 8
Modena 8
Mumbai 8
Rio Saliceto 8
Amsterdam 7
Bangkok 7
Budapest 7
Frankfurt am Main 7
Kocaeli 7
Totale 9.580
Salva come PNG Salva come JPEG
Nome #
Incidence of acute myeloid leukemia after breast cancer 333
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 300
Factors associated with mortality in bacteremic patients with haematologic malignancies 295
Factors associated with mortality in bacteremic patients with hematologic malignancies. 295
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 292
A prospective survey of febrile events in hematological malignancies 245
Therapy-related leukemias and myelodysplasia : susceptibility and incidence. 218
Systemic granulomatous reaction secondary to treatment of bladder cancer with Bacillus Calmette-Guerin 163
A cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature 161
Factors associated with mortality in bacteremic patients with hematologic malignancies. 159
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. 155
Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay 148
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 140
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 129
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 129
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 128
Impaired bactericidal and fungicidal activities of neutrophils in patients with myelodysplastic syndrome 121
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 120
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. 120
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 118
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 117
Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect 117
Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia. 112
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 112
Primary plasma cell leukemia followed by testicular plasmacytoma 108
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 108
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). 106
All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients 106
Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto SCTsuccessfully treated with combination treatment. 105
Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency 105
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 104
Adjuvant therapy with rhGM-CSF for the treatment of Blastoschizomyces capitatus systemic infection in a patient with acute myeloid leukemia 102
Epigenetic changes in therapy-related MDS/AML 101
Similarities and differences between therapy-related and elderly acute myeloid leukemia 101
Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 101
A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia 100
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 99
5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature 99
Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases 99
Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol. 97
Hyperleukocytosis and leukostasis: management of a medical emergency 97
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias 96
Hyperleukocytosis and leukostasis: management of a medical emergency 96
A prospective survey of febrile events in hematological malignancies 95
A prospective survey of febrile events in hematological malignancies 94
Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registry 94
A patient with acute myeloid leukemia and a solid mass in the colon. 93
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 93
Outcome of therapy-related myeloid neoplasms treated with azacitidine 92
Serum beta 2 microglobulin in psoriasis and psoriatic patients 91
Uncommon yeast infections in hematological patients: from diagnosis to treatment 91
Invasive Aspergillosis in patients with acute leukemia: update on morbidity and mortality--SEIFEM-C Report. 90
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality 89
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry 89
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study 88
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 88
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 88
Changes in the incidence of candidemia and related mortality in patients with hematologic malignancies in the last ten years. A SEIFEM 2015-B report 88
ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients 86
Hema e-Chart: Italian Registry for prospective analysis of epidemiology, management and outcome of febrile events in patients with hematological malignancies 85
Scedosporiosis in patients with acute leukemia: a retrospective multicenter report 85
SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients 85
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 85
Caspofungin for the treatment of candidaemia in patients with haematological malignancies 84
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 84
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 84
Advanced mast cell disease: an Italian Hematological Multicenter experience. 83
High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma. 83
Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies 83
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 81
Immature platelet fraction (IPF) in hospitalized patients with neutrophilia and suspected bacterial infection 81
Granulocyte transfusions as adjunctive treatment of invasive fungal diseases in neutropenic patients 81
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 80
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 80
In vitro susceptibility of Candida species isolated from patients with haematological malignancies 79
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 79
Tunneling Schmorl?s Nodes in an Elderly Woman Treated for Acute Lymphoblastic Leukemia. 78
Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies 76
Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule 75
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 75
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 75
First case of breakthrough pneumonia due to Aspergillus nomius in a patient with acute myeloid leukemia 74
ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients 74
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project 73
Negative prognostic value of glutathione s-transferase (gstm1 and gstt1) deletions in adult acute myeloid leukemia. 73
Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches 73
SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disorders 73
A prospective, multicentre survey on antifungal therapy in neutropenic paediatric haematology patients 72
Improved Detection of Minimal Residual Disease by 11C-Methionine PET/CT in a Young Patient With Unusual Extramedullary Presentation of Recurrent Multiple Myeloma 72
Uncommon mold infections in hematological patients: epidemiology, diagnosis and treatment 69
Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B? 69
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project 68
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 68
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 67
The role of primary antifungal prophylaxis in patients with haematological malignancies 66
Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey 66
Retrospective Chart Review of Hospitalisations During Chemotherapy for Adult Patients with Ph-Negative B-Precursor Relapsed or Refractory (R/R) Acute Lymphoblastic Leukaemia (All) In Italy 66
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 66
The role of Gemtuzumab Ozogamicin in the treatment of acute myeloid leukemia patients. 65
Current therapeutic approaches to fungal infections in immunocompromised hematological patients 65
Totale 10.706
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.549
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.549
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.511 490 155 125 137 224 271 233 95 162 159 209 251
2020/20211.862 97 208 44 181 241 125 247 52 220 72 348 27
2021/20222.205 260 151 34 88 149 76 33 334 115 156 332 477
2022/20234.610 525 562 397 773 365 588 167 373 561 94 158 47
2023/20242.512 126 738 92 81 95 351 203 51 36 91 302 346
2024/2025142 142 0 0 0 0 0 0 0 0 0 0 0
Totale 18.566